The primary purpose of this study was to investigate the anti-inflammatory effects of two of the non-psychotropic cannabinoids, cannabidiol (CBD) and Cannabigerol (CBG) alone and in combination, in a model of pulmonary inflammation. The results of the work suggest that the cannabinoids CBD and CBG in combination have significant anti-inflammatory activity in the lung.
The Sativa Group sponsored the study as part of its research agreement. The full research paper which can be found at;
https://www.sciencedirect.com/science/article/abs/pii/S1094553921000596